Advocacy tools

Articles in this section

  • Minimum costs to produce Hepatitis C Direct Acting Antivirals by Andrew Hill, Bryony Simmons, Nikolien van de Van, Nathan Ford, Saye Khoo and Joe Fortunak

  • 1st Hepatitis C Virus World Community Advisory Board Report July 14, 2014 - By Odilon Couzin and Karyn Kaplan

  • Nobody Left Behind The importance of integrating people who inject drugs into HCV treatment programs. Arguments from a public health and human rights perspective.